Researcher
Astrid Van den Eynde
- Keywords:Medicine
- Disciplines:Cancer therapy, Gastro-enterology
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From15 Oct 2019 → Today
Projects
1 - 1 of 1
- Unravelling the synergistic potential of CD70directed CAR natural killer cells with firstline chemotherapy in 3D culture models as a novel combination treatment for metastatic colorectal cancer patients.From1 Jan 2024 → TodayFunding: Nonprofit institution or equivalents
Publications
1 - 4 of 4
- IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts(2024)
Authors: Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, Ho Wa Lau, Christophe Hermans, Hilde Lambrechts, Tal Flieswasser, Delphine Quatannens, Gils Roex, Karen Zwaenepoel, et al.
Pages: 1 - 19 - Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer(2023)
Authors: Tal Flieswasser, Astrid Van den Eynde, Laurie Freire Boullosa, Jöran Melis, Christophe Hermans, Céline Merlin, Ho Wa Lau, Jonas Van Audenaerde, Filip Lardon, Evelien Smits, et al.
Pages: 1 - 11 - The CD70-CD27 axis in oncology(2022)
Authors: Tal Flieswasser, Astrid Van den Eynde, Jonas Van Audenaerde, Jorrit De Waele, Filip Lardon, Carsten Riether, Hans de Haard, Evelien Smits, Patrick Pauwels, Julie Jacobs
- Clinically relevant chemotherapeutics have the ability to induce immunogenic cell death in non-small cell lung cancer(2020)
Authors: Tal Flieswasser, Jinthe Van Loenhout, Laurie Freire Boullosa, Astrid Van den Eynde, Jorrit De Waele, Jonas Van Audenaerde, Filip Lardon, Evelien Smits, Patrick Pauwels, Julie Jacobs
Patents
1 - 1 of 1
- Cell-based therapeutics targeting CD70 (Inventor)